These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19587659)

  • 21. Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.
    Bailey S; Singh A; Azadian R; Huber P; Blum M
    Drug Saf; 2010 Feb; 33(2):139-46. PubMed ID: 20082540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities.
    Ursem CJ; Kruhlak NL; Contrera JF; MacLaughlin PM; Benz RD; Matthews EJ
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):1-22. PubMed ID: 19422096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardizing drug adverse event reporting data.
    Wang L; Jiang G; Li D; Liu H
    Stud Health Technol Inform; 2013; 192():1101. PubMed ID: 23920875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.
    Li AS; Pomeranz HD
    J Neuroophthalmol; 2016 Dec; 36(4):480-481. PubMed ID: 27851718
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
    Muñoz MA; Delcher C; Dal Pan GJ; Kortepeter CM; Wu E; Wei YJ; Xiao H; Winterstein AG
    Pharmacotherapy; 2019 Nov; 39(11):1042-1052. PubMed ID: 31479525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).
    Poluzzi E; Raschi E; Moretti U; De Ponti F
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):512-8. PubMed ID: 19358226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Database size and power to detect safety signals in pharmacovigilance.
    Hammond IW; Gibbs TG; Seifert HA; Rich DS
    Expert Opin Drug Saf; 2007 Nov; 6(6):713-21. PubMed ID: 17967160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
    Huang L; Zalkikar J; Tiwari RC
    J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
    de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
    PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
    Khadem TM; van Manen RP; Brown J
    Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
    Brown J; Aitken SL; van Manen RP
    Pharmacotherapy; 2011 Jun; 31(6):585-90. PubMed ID: 21923442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use.
    Holoshitz N; Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2008 Jan; 101(1):95-7. PubMed ID: 18157972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scientists mine web search data to identify epidemics and adverse events.
    Kuehn BM
    JAMA; 2013 May; 309(18):1883-4. PubMed ID: 23652502
    [No Abstract]   [Full Text] [Related]  

  • 34. Statistical Mining of Potential Drug Interaction Adverse Effects in FDA's Spontaneous Reporting System.
    Harpaz R; Haerian K; Chase HS; Friedman C
    AMIA Annu Symp Proc; 2010 Nov; 2010():281-5. PubMed ID: 21346985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public-released version of the Adverse Event Reporting System (AERS) database.
    Strauss A; Lawrence Gould A; Nelsen LM; Wiholm BE; Jones JK
    Clin Ther; 2005 Mar; 27(3):355-7; author reply 357-9. PubMed ID: 15878390
    [No Abstract]   [Full Text] [Related]  

  • 37. Reporting Adverse Drug Events.
    Feagins LA; Abdelsayed GG; Schairer J;
    Am J Gastroenterol; 2019 Sep; 114(9):1411-1413. PubMed ID: 31464745
    [No Abstract]   [Full Text] [Related]  

  • 38. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
    Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
    Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase
    Vogel U; van Stekelenborg J; Dreyfus B; Garg A; Habib M; Hosain R; Wisniewski A
    Drug Saf; 2020 Apr; 43(4):351-362. PubMed ID: 32020559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring pharmacogenetic difference using adverse event database: an example of clopidogrel and cardiovascular events.
    Joung KI; Kim KH; Hsieh CY; Shin JY
    Pharmacogenomics; 2020 Nov; 21(16):1157-1168. PubMed ID: 33118441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.